Trikafta Kit
RxNorm Crosswalk NDC 51167-331

View RxNorm Concepts, RxCUIs, and Term Type mappings for this NDC

RxNorm Mapping Clinical Concepts

This drug is included in the RxNorm Current Prescribable Content, a subset of RxNorm that includes all drugs available for prescription in the United States.

The product Trikafta (NDC 51167-331) is cross-mapped to the RxNorm terminology system to ensure clinical interoperability. This product is associated with 16 unique RxNorm concepts. By anchoring Vertex Pharmaceuticals Incorporated's product data to these standardized identifiers, healthcare systems can maintain accurate medication records, safely automate e-prescribing, and streamline pharmacy workflows.

The following clinical concept cards detail the semantic term types (TTY), prescribable names, and synonymous clinical strings as defined by the National Library of Medicine (NLM).

SCDPrescribable
Featured Concept

ivacaftor 150 MG Oral Tablet
(RxCUI 1243046)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

ivacaftor 75 MG Oral Granules
(RxCUI 1606868)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

ivacaftor 75 MG Oral Tablet
(RxCUI 2174388)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet
(RxCUI 2257011)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet (56) and ivacaftor 150 MG Oral Tablet (28) Pack
(RxCUI 2257012)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

trikafta 100 MG / 50 MG / 75 MG and 150 MG Tablet Pack
(RxCUI 2257013)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet
(RxCUI 2557214)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

elexacaftor 50 MG / ivacaftor 37.5 MG / tezacaftor 25 MG Oral Tablet (56) and ivacaftor 75 MG Oral Tablet (28) Pack
(RxCUI 2557215)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

trikafta 50 MG / 37.5 MG / 25 MG and 75 MG Pack
(RxCUI 2557216)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules
(RxCUI 2635013)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

SCDPrescribable
Featured Concept

ivacaftor 59.5 MG Oral Granules
(RxCUI 2635020)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

elexacaftor 80 MG / ivacaftor 60 MG / tezacaftor 40 MG Oral Granules (28) / ivacaftor 59.5 MG Oral Granules (28) Pack
(RxCUI 2635021)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

trikafta 80 MG / 40 MG / 60 MG and 59.5 MG Oral Granules Pack
(RxCUI 2635022)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

SCDPrescribable
Featured Concept

elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules
(RxCUI 2635024)

Semantic Clinical Drug

Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.

PSNPrescribable
Featured Concept

elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Granules (28) / ivacaftor 75 MG Oral Granules (28) Pack
(RxCUI 2635025)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

PSNPrescribable
Featured Concept

trikafta 100 MG / 50 MG / 75 MG and 75 MG Oral Granules Pack
(RxCUI 2635026)

Prescribable Name

Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.

Understanding RxNorm Mapping for Trikafta

RxNorm is a normalized naming system developed by the National Library of Medicine (NLM) to bridge the gap between different drug terminologies. By mapping NDC 51167-331 to RxCUI 1243046, 1606868, 2174388, 2257011, 2257012, 2257013, 2557214, 2557215, 2557216, 2635013, 2635020, 2635021, 2635022, 2635024, 2635025, 2635026, this page provides the standardized "source of truth" required for hospital systems, e-prescribing software, and pharmacy benefit managers (PBMs) to communicate without errors.

Term Type (TTY) Legend for This Page

The clinical cards above utilize specific Term Types (TTY) to define the granularity of the drug concept:

  • PSN Prescribable Name: The standardized name preferred by electronic prescribing (eRx) applications for display.
  • SCD Semantic Clinical Drug: The clinical gold standard representing the Generic Name + Strength + Dosage Form.
  • GPCK Generic Pack: A standardized concept for a clinical kit containing multiple generic components.
  • SY Synonym: An alternative clinical name or alias provided for search and retrieval clarity.
  • BPCK Branded Pack: A standardized concept for a clinical kit containing multiple branded components.

* Please review the full disclaimer at the bottom of this page.